Journal of Obesity & Metabolic Syndrome
Scope & Guideline
Championing Open Access for Groundbreaking Research
Introduction
Aims and Scopes
- Obesity and Metabolic Syndrome Research:
The journal primarily focuses on studies related to obesity and metabolic syndrome, investigating their prevalence, risk factors, and health consequences across various populations. - Clinical and Translational Research:
Research articles often include clinical trials, observational studies, and translational research that bridge laboratory findings with clinical applications to improve patient outcomes. - Behavioral and Lifestyle Interventions:
The journal emphasizes the role of lifestyle modifications, including diet, exercise, and behavioral therapies, in the prevention and management of obesity and metabolic syndrome. - Emerging Therapeutics and Pharmacological Interventions:
There is a consistent focus on new pharmacological treatments and therapeutic approaches for obesity management, including the evaluation of anti-obesity medications and their mechanisms. - Comorbidities and Associated Health Risks:
Research frequently explores the relationship between obesity and various comorbid conditions such as cardiovascular diseases, diabetes, and cognitive impairments. - Public Health and Policy Implications:
The journal addresses public health strategies and policy recommendations aimed at combating the obesity epidemic and promoting metabolic health at the population level.
Trending and Emerging
- Impact of COVID-19 on Obesity and Metabolic Health:
Recent publications increasingly address the implications of the COVID-19 pandemic on obesity rates, management strategies, and associated health risks, highlighting the urgent need for adaptive interventions. - Technological Interventions for Weight Management:
There is a growing trend towards the use of mobile health applications and digital tools for weight management and obesity prevention, signaling an integration of technology in behavioral health interventions. - Gut Microbiome and Metabolic Health:
Research exploring the role of the gut microbiome in metabolic dysregulation and obesity is gaining momentum, indicating a shift towards understanding the microbiome's impact on health outcomes. - Personalized Medicine Approaches:
Emerging studies focus on personalized approaches to obesity treatment, including genetic, metabolic, and phenotypic assessments to tailor interventions for individual patients. - Mental Health and Obesity:
There is an increasing recognition of the interplay between mental health and obesity, with more research investigating psychological factors and their influence on obesity management and outcomes.
Declining or Waning
- Traditional Diet Interventions:
There has been a noticeable decline in studies focusing solely on traditional diet interventions without incorporating modern behavioral or technological components, suggesting a shift towards more integrative approaches. - Static Epidemiological Studies:
The journal has seen fewer static epidemiological studies that do not consider dynamic factors such as lifestyle changes during the COVID-19 pandemic, indicating a preference for more responsive research designs. - Longitudinal Studies on Childhood Obesity:
Research on childhood obesity has become less frequent, suggesting a potential waning interest or a shift towards addressing obesity in adult populations and its immediate health consequences. - Animal Model Studies:
The frequency of animal model studies related to obesity and metabolic syndrome appears to be decreasing, possibly in favor of more clinically relevant human studies that can directly inform practice.
Similar Journals
TRENDS IN ENDOCRINOLOGY AND METABOLISM
Transforming understanding of metabolism and disease.TRENDS IN ENDOCRINOLOGY AND METABOLISM, published by CELL PRESS, stands as a pivotal resource in the fields of endocrinology, diabetes, and metabolism. With its ISSN 1043-2760 and E-ISSN 1879-3061, this esteemed journal has been a leading platform since its inception in 1989, currently projected to span until 2024. Recognized within the top quartile (Q1) of its category, it boasts impressive Scopus rankings, holding the 4th position in Endocrinology and 8th in Endocrinology, Diabetes, and Metabolism. These rankings underscore its significant impact, evidenced by an impressive percentile rank of 97th and 96th respectively. The journal is committed to facilitating the dissemination of cutting-edge research and innovative insights, making it an essential read for researchers, clinicians, and students seeking to stay informed on the latest advancements in these critical fields. With a robust focus on providing thorough reviews and original research articles, TRENDS IN ENDOCRINOLOGY AND METABOLISM continues to shape the understanding and treatment of metabolic disorders.
Clinical Obesity
Leading the Charge in Obesity ResearchClinical Obesity, published by WILEY, is a leading journal in the field of Endocrinology, Diabetes, and Metabolism that strives to advance the understanding of obesity-related health issues. With an ISSN of 1758-8103 and an E-ISSN of 1758-8111, this journal provides a platform for cutting-edge research and findings pertaining to the epidemiology, pathophysiology, prevention, and treatment of obesity. Recognized with a Q2 ranking in both Endocrinology, Diabetes and Metabolism and Medicine (miscellaneous) categories, and boasting a Scopus rank of #90 out of 244, Clinical Obesity encompasses innovative studies that influence clinical practice and public health policies. While this journal operates under a subscription model, its discipline-specific contributions are invaluable for researchers, healthcare professionals, and students keen on addressing the complexities of obesity in a comprehensive manner.
Annals of Pediatric Endocrinology & Metabolism
Elevating standards in pediatric endocrine research and practice.Annals of Pediatric Endocrinology & Metabolism, published by the Korean Society of Pediatric Endocrinology, is a vital resource for researchers, healthcare professionals, and students in the fields of endocrinology, diabetes, and pediatric health. With its commitment to open access since 2012, the journal facilitates the dissemination of groundbreaking research on pediatric endocrine disorders and metabolic diseases, ensuring that vital knowledge is accessible to a global audience. The journal maintains a reputable standing with a 2023 Scopus rank of #92 in Pediatrics and a Q3 quartile in Endocrinology, highlighting its impact on the field. Originating from South Korea, the journal fosters a collaborative network of researchers and advocates best practices in pediatric care through interdisciplinary studies. The Annals not only enhances scientific understanding but also emphasizes practical applications aimed at improving child health outcomes, making it an essential publication for academics and practitioners alike.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
Navigating the complexities of endocrine and metabolic health.REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, published by Springer, is a leading journal in the field of endocrinology, diabetes, and metabolism, with an impressive Q1 ranking in both categories as of 2023. With an ISSN of 1389-9155 and E-ISSN 1573-2606, this journal serves as a vital resource for researchers, clinicians, and students seeking comprehensive reviews that address the latest advancements and interdisciplinary approaches in the management of endocrine and metabolic disorders. Operating from the Netherlands, it features articles that are rigorously peer-reviewed and is notable for its significant impact factor reflected in its Scopus rankings, placing it in the top percentile of its categories. Although it does not currently offer open access, it provides critical insights applicable to both basic and clinical settings, making it indispensable for those dedicated to enhancing patient outcomes in endocrine health.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
Transforming Clinical Insights into Endocrine SolutionsEXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES is a distinguished journal published by GEORG THIEME VERLAG KG, dedicated to advancing research and understanding in the fields of endocrinology, diabetes, and metabolism. With an ISSN of 0947-7349 and an E-ISSN of 1439-3646, this journal serves as a critical platform for disseminating high-quality research findings, reviews, and clinical studies from 1983 to 2024. The journal holds an impactful position within its respective categories, notably achieving Q3 in Endocrinology and Diabetes and Metabolism, and Q2 in Internal Medicine as per the 2023 category quartiles. Additionally, it ranks in the 57th and 46th percentiles in the Scopus rankings for Internal Medicine and Endocrinology, Diabetes and Metabolism, respectively. Though not an open-access publication, the journal caters to a global audience of researchers, professionals, and students, facilitating knowledge exchange and fostering collaboration within this vital area of medical science.
Current Obesity Reports
Driving research to combat the obesity epidemic.Current Obesity Reports, an esteemed journal published by SPRINGER, serves as a pivotal platform for scholars and practitioners in the field of obesity research. With its ISSN of 2162-4968, this journal has been recognized within the competitive landscape of Medicine & Internal Medicine, achieving a commendable Scopus rank of #11 out of 167, placing it in the top 93rd percentile. Launched in 2012 and covering critical developments in obesity up to 2024, this journal synthesizes innovative research, evidence-based practices, and comprehensive reviews that cater to a diverse audience, from researchers to public health professionals. While currently not offering open access options, it remains dedicated to advancing knowledge and fostering discussions that address the multifaceted issues related to obesity, its public health implications, and treatment methodologies. For those involved in tackling obesity challenges, Current Obesity Reports stands as a vital resource, contributing significantly to the discourse and scholarship in the field.
Cardiovascular Endocrinology & Metabolism
Unlocking the Connections Between Heart and Hormonal HealthCardiovascular Endocrinology & Metabolism is a leading open-access journal dedicated to advancing our understanding of the interconnections between cardiovascular health and endocrine functions. Published by Lippincott Williams & Wilkins, this journal serves as a vital resource for researchers and clinicians alike, providing timely insights into the intricate relationships between metabolic disorders and cardiovascular diseases. With an impressive impact factor and categorized in Q2 for both Cardiology and Cardiovascular Medicine as well as Endocrinology, Diabetes, and Metabolism, it holds a significant position within its respective fields. The journal has been fully open access since its inception in 2012, ensuring that critical research is accessible to a global audience. By fostering innovation and collaboration, Cardiovascular Endocrinology & Metabolism aims to promote better health outcomes and stimulate novel research directions, making it an essential resource for professionals striving to bridge the gaps between these two critical domains.
Therapeutic Advances in Endocrinology and Metabolism
Advancing the frontiers of endocrine health.Therapeutic Advances in Endocrinology and Metabolism is a premier open-access journal published by SAGE Publications Ltd that has established itself as a leading platform for research in the field of endocrinology, diabetes, and metabolism. With a commitment to disseminating high-quality research, the journal aims to advance our understanding of therapeutic interventions and innovations in the management of endocrine disorders. Since its inception in 2010, it has garnered a strong reputation, attaining a Q1 quartile ranking in 2023 in its category and boasting a respectable Scopus rank of #53 out of 244, positioning it within the 78th percentile. As an open-access journal since 2019, Therapeutic Advances in Endocrinology and Metabolism ensures that valuable research findings are accessible to a global audience, fostering collaboration and knowledge sharing among researchers, clinicians, and students alike. The journal's multifaceted objectives encompass the publication of original research, reviews, and clinical studies that contribute to the evolving dialogue surrounding endocrine health. By delivering timely and robust content, it serves as an indispensable resource for those striving to make significant contributions to this vital area of medical science.
Journal of the ASEAN Federation of Endocrine Societies
Leading the Charge: Advances in Endocrine Knowledge and PracticeWelcome to the Journal of the ASEAN Federation of Endocrine Societies, a pioneering publication dedicated to advancing knowledge and research in the fields of Endocrinology, Diabetes, and Metabolism. Established by the ASEAN Federation Endocrine Society and open access since 2011, this journal enhances the dissemination of critical findings and encourages collaboration among professionals and researchers across Southeast Asia and beyond. With an ISSN of 0857-1074 and E-ISSN of 2308-118X, the journal is indexed within Quartile 4 in the 2023 rankings of its categories, reflecting its commitment to providing a platform for scholarly work despite its emerging status. Situated in the Philippines, the journal focuses on the latest trends, treatments, and innovative research approaches in endocrinology, making it an essential resource for academics, clinicians, and students alike. We invite you to explore our content and contribute to advancing the endocrine sciences.
Current Opinion in Endocrinology Diabetes and Obesity
Elevating Understanding of Endocrine HealthCurrent Opinion in Endocrinology, Diabetes and Obesity, published by LIPPINCOTT WILLIAMS & WILKINS, offers a critical analysis of the latest advancements and trends in the fields of endocrinology, diabetes, and obesity. With an ISSN of 1752-296X and an E-ISSN of 1752-2978, this esteemed journal provides an authoritative platform for researchers, clinicians, and healthcare professionals to stay updated on emerging research and clinical practices. Renowned for its impactful contributions, the journal holds notable rankings, including Q2 in Endocrinology and Diabetes & Metabolism, as well as a commendable Q1 in Internal Medicine, reflecting its significance in the academic community. Although currently not an open access publication, articles published from 2007 to 2024 continually enrich the discourse on pressing health issues related to endocrinology and metabolic disorders. By fostering a comprehensive understanding of the complexities within these interconnected fields, it serves as an essential resource for any professional or student engaged in health science research.